Muhammad Abdulghani, PhD, MD

Principal Scientist

  • 7521 Citations
  • 44 h-Index
1989 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Clinical Research

External positions

Fingerprint Dive into the research topics where Muhammad Abdulghani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG

Alatrach, M., Agyin, C., Mehta, R., Adams, J., DeFronzo, R. A. & Abdulghani, M., 1 Jan 2019, In : The Journal of clinical endocrinology and metabolism. 104, 1, p. 163-171 9 p.

Research output: Contribution to journalArticle

  • 2 Citations (Scopus)

    Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes

    DeFronzo, R. A., Inzucchi, S., Abdulghani, M. & Nissen, S. E., 1 Mar 2019, In : Diabetes and Vascular Disease Research. 16, 2, p. 133-143 11 p.

    Research output: Contribution to journalArticle

  • 12 Citations (Scopus)

    Pioglitazone prevents the increase in plasma ketone concentration associated with dapagliflozin in insulin-treated T2DM patients: Results from the Qatar Study

    Abdulghani, M., Migahid, O., Megahed, A., Singh, R., Fawaz, M., DeFronzo, R. A. & Jayyousi, A., 1 Mar 2019, In : Diabetes, Obesity and Metabolism. 21, 3, p. 705-709 5 p.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    Effect of chronic hyperglycemia on glucose metabolism in subjects with normal glucose tolerance

    Shannon, C., Merovci, A., Xiong, J., Tripathy, D., Lorenzo, F., McClain, D., Abdulghani, M., Norton, L. & DeFronzo, R. A., 1 Dec 2018, In : Diabetes. 67, 12, p. 2507-2517 11 p.

    Research output: Contribution to journalArticle

  • 10 Citations (Scopus)

    Empagliflozin Treatment Is Associated with Improved β -Cell Function in Type 2 Diabetes Mellitus

    Al Jobori, H., Daniele, G., Adams, J., Cersosimo, E., Solis-Herrera, C., Triplitt, C., Defronzo, R. A. & Abdulghani, M., 1 Apr 2018, In : Journal of Clinical Endocrinology and Metabolism. 103, 4, p. 1402-1407 6 p.

    Research output: Contribution to journalArticle

  • 17 Citations (Scopus)